Original Research
Accepted on 10 Oct 2025
Knockdown of TOP2A Reverses Cisplatin 1 Resistance in Ovarian Cancer by Inhibiting 2 EMT via Ferroptosis Mediated by the 3 TP53/GPX4/SLC7A11 Axis 4
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 10 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 10 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 10 Oct 2025
in B Cell Biology
Original Research
Accepted on 10 Oct 2025
in Alloimmunity and Transplantation
Original Research
Accepted on 10 Oct 2025
in Inflammation
Original Research
Accepted on 10 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 10 Oct 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 10 Oct 2025
in Mucosal Immunity
Editorial
Accepted on 10 Oct 2025
in Mucosal Immunity
Original Research
Accepted on 10 Oct 2025
in Molecular Innate Immunity
Original Research
Accepted on 10 Oct 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Review
Accepted on 10 Oct 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 10 Oct 2025
in Molecular Innate Immunity
Original Research
Accepted on 10 Oct 2025
in Vaccines and Molecular Therapeutics
Editorial
Accepted on 10 Oct 2025
in Cancer Immunity and Immunotherapy
Editorial
Accepted on 10 Oct 2025
in Viral Immunology